Form 4: iRhythm Officer Granted 10,870 RSUs

iRhythm Holdings' Chief Communications & Product Officer, Chad Patterson, received a grant of 10,870 Restricted Stock Units.

Summary

• Chad Patterson, Chief Communications & Product Officer of iRhythm Holdings, Inc. (IRTC), was granted 10,870 shares of common stock in the form of Restricted Stock Units (RSUs).
• The transaction occurred on February 25, 2026, with a deemed execution date on the same day.
• The acquisition price for these RSUs was $0 per share, as is typical for equity grants.
• Following this transaction, Chad Patterson beneficially owns 62,608 shares of iRhythm Holdings, Inc. common stock.
• The RSUs will vest 25% on March 1, 2027, and 25% on each subsequent one-year anniversary, contingent on Chad Patterson's continued service to the company.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development, indicating continued executive commitment and a standard practice for long-term incentive alignment, which is generally favorable for corporate governance.

Positives

• The grant of 10,870 Restricted Stock Units to a key executive, Chad Patterson, aligns his long-term interests with those of shareholders.
• Equity-based compensation at a $0 acquisition price is a common and effective method for retaining and incentivizing senior management.

Negatives

• No immediate cash inflow for the executive from this grant, as it is equity-based compensation with a vesting schedule.
• The value of the compensation is subject to future stock price performance, introducing market risk for the executive.

Risks

• The vesting of the 10,870 Restricted Stock Units is contingent upon Chad Patterson's continued service as a service provider through each vesting date.
• The ultimate value realized from these RSUs is subject to the future market price fluctuations of iRhythm Holdings, Inc. common stock.

Future Outlook

The vesting schedule for the granted Restricted Stock Units indicates future share distribution, with 25% vesting annually starting March 1, 2027, contingent on continued service.

Management Comments

• Chad Patterson, Chief Communications & Product Officer, received a grant of 10,870 Restricted Stock Units as part of his compensation.

Industry Context

StockSavvy.ai notes that RSU grants are a common form of executive compensation in the medical device and technology industry, designed to align long-term incentives between executives and shareholders.

Comparison to Industry Standards

• RSU grants with multi-year vesting schedules are standard practice for executive retention and incentive in the technology and medical device sectors, comparable to compensation strategies at companies like Medtronic or Boston Scientific, which also utilize equity awards to incentivize long-term performance and executive alignment.

Stakeholder Impact

• Shareholders benefit from aligned management incentives, as the executive's compensation is tied to the company's long-term stock performance.
• The executive, Chad Patterson, receives future equity, incentivizing his continued service and contribution to the company's success.

Next Steps

• 25% of the granted RSUs will vest on March 1, 2027, subject to Chad Patterson's continued service.
• Subsequent 25% portions of the RSUs will vest on each one-year anniversary thereafter, contingent on continued service.

Key Dates

Recommendation

This Form 4 filing details a routine RSU grant to an executive, which is a standard compensation practice and does not present new information that would significantly alter the investment thesis for iRhythm Holdings. It reinforces management's long-term alignment but does not provide a catalyst for a 'buy' or 'sell' recommendation.

Keywords

iRhythm Holdings, IRTC, Chad Patterson, RSU, Restricted Stock Units, Stock Grant, Executive Compensation, Form 4